# Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness

> **NCT06245421** · NA · COMPLETED · sponsor: **Horus Pharma** · enrollment: 85 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DEVICE:** DM934
- **DEVICE:** Théalose

## Key facts

- **NCT ID:** NCT06245421
- **Lead sponsor:** Horus Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-07
- **Primary completion:** 2024-08-12
- **Final completion:** 2024-09-30
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245421, "Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06245421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*